We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 0.27% | 36.85 | 36.85 | 37.10 | 37.05 | 36.25 | 36.40 | 449,522 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 217.94 | 200.13M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/5/2018 18:34 | Lucicavi - Jog on mate, you're an imbecile. I remember filtering you on the IMM board due to the utter pish you posted there. | slammer1888 | |
21/5/2018 14:14 | If Diclectin news tomorrow this is worth 150p | lucicavi | |
21/5/2018 14:00 | then kiss 120p | lucicavi | |
21/5/2018 13:30 | Looks ready to kiss that magic 100p | lucicavi | |
20/5/2018 13:07 | Heading to 100p sometime very soon | opodio | |
18/5/2018 17:34 | Very much liking the volume pattern here. Since the final results the daily volumes traded exceeding 1m are the norm (corresponding exactly with the price break out); before that they were a rarity. If anything, the consistency of volumes exceeding 1m has increased during May, today's volume being no exception. | firtashia | |
16/5/2018 15:29 | It looks more like a reduction (from 9.90% to 4.78%). Either way, a positive effect on the share price! | joeywald | |
16/5/2018 10:57 | Quality company, big volume yesterday, breaking out. Stocko rankings excellent (74/47/98 overall 89), TA beautiful, tipsters supportive and even that old hound Robbie Burns on board. | mad foetus | |
16/5/2018 10:53 | wots goin on ere then? | volsung | |
16/5/2018 10:41 | Looking lively this morning, surprised it has taken so long but now poised to break out. | mad foetus | |
11/5/2018 04:54 | Take a look at HEMO, Hemogenyx, who recently came to the market and are developing a new approach to bone marrow transplant proceedure. Compelling story, talented management/research team, blue chip collaboration partners, and Cornell University is a shareholder. | badger60 | |
09/5/2018 16:14 | Thanks, bugrit. | dogwalker | |
09/5/2018 10:18 | Small Company Share Watch. | bugrit | |
09/5/2018 07:47 | 'SCSW', please...? | dogwalker | |
08/5/2018 15:51 | Joined you this morning here. Has been on the Watch List & I thought I had missed an opportunity when I saw the SCSW tip. Surprised the share price hasn't risen today but sometimes there is a lag for no obvious reason. | martinthebrave | |
08/5/2018 15:08 | I am one as well, topped up.Suprised that they haven't risen this morning. First bought in 2009 for 23p, sold most since . Good write up in SCSW . Solid performer and expanding into China I believe. | malcolmmm | |
27/4/2018 09:11 | HUge stream of buys going through; admittedly I am two of them, but some consistent buying here. | silverfern | |
26/4/2018 16:29 | See the Naked Trader has bought again and is looking for a pound. I am to,I remember when I would have laughed at the suggestion that this could reach a pound, but now I think it's entirely possible | buying | |
26/4/2018 12:02 | Mightn't be too far away at this rate buying. Nice to see 80p breached | volsung | |
17/4/2018 19:01 | See Numis have increased their target to 88p. For patient investors £1 could be achievable one day | buying | |
17/4/2018 15:30 | Just to mention that Alliance Pharma are presenting at the huge Mello2018 investor event at the end of this month so good timing with results just out. They have never presented at a Mello event before and John Dawson is scheduled to present on Friday 27th April at 1.40pm. Here is the link if any of you would like to come along and meet them.... | davidosh |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions